Artal International S.C.A.

CIK 000121818013 companiesTHOUSAND OAKS, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001218180

Recent Transactions

50 trades

Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-11-18$134.13/sh−8,000,000→ 9,507,990 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-08-26$116.36/sh−6,000,000→ 17,507,990 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-06-05$87.25/sh−3,000,000→ 23,507,990 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2024-05-10+57,546,100→ 136,180,481 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10$108.50/sh+1,150,922→ 1,150,922 total
Exercise/Conversion
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-05-10−1,150,922→ 0 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-03-21$66.25/sh−2,000,000→ 26,507,990 total
Award
LEXICON PHARMACEUTICALS, INC.$LXRX
Series A Convertible Preferred Stock
2024-03-13$108.50/sh+1,150,922→ 1,150,922 total
Sale
CAVA GROUP, INC.$CAVA
Common Stock
2024-02-27$53.60/sh−3,500,000→ 28,507,990 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$8.55/sh+10,150→ 11,259,438 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-10-12$6.85/sh+2,189,781→ 11,249,288 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,568,865→ 1,568,865 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series E Preferred Stock
2023-06-20−22,252,464→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+861,339→ 7,762,434 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+22,252,464→ 30,014,898 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series D Preferred Stock
2023-06-20−861,339→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series A Preferred Stock
2023-06-20−1,568,865→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,845,864→ 6,901,095 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+3,486,366→ 5,055,231 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series F Preferred Stock
2023-06-20−1,993,092→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series B Preferred Stock
2023-06-20−3,486,366→ 0 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Common Stock
2023-06-20+1,993,092→ 32,007,990 total
Exercise/Conversion
CAVA GROUP, INC.$CAVA
Series C Preferred Stock
2023-06-20−1,845,864→ 0 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2023-06-05$2.60/sh+27,775,050→ 78,634,381 total
Sale
WW INTERNATIONAL, INC.$WW
Common Stock
2023-05-10$7.15/sh−14,818,300→ 0 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-04-28$6.43/sh+31,557→ 9,059,507 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-24$1.70/sh+100,000→ 8,589,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-23$1.75/sh+200,000→ 8,489,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-22$1.79/sh+150,000→ 8,289,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-21$1.85/sh+50,000→ 8,139,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-17$1.71/sh+200,000→ 8,089,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-16$1.68/sh+315,266→ 7,889,064 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-15$2.16/sh+1,000,000→ 7,573,798 total
Purchase
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2023-02-09$3.24/sh+11,451→ 6,573,798 total
Sale
Scholar Rock Holding Corp$SRRK
Common Stock
2023-01-09$9.48/sh−1,094→ 9,027,950 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2023-01-05$9.33/sh+48,774→ 9,029,044 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-25$8.04/sh+130,265→ 8,980,270 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-04$7.89/sh+66,000→ 8,850,005 total
Purchase
Scholar Rock Holding Corp$SRRK
Common Stock
2022-10-03$7.03/sh+33,971→ 8,784,005 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-05$2.50/sh+2,426,070→ 50,859,331 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2022-08-01$2.50/sh+16,173,800→ 48,433,261 total
Conversion
Omega Therapeutics, Inc.
Common Stock
2021-08-03+1,323,530→ 1,398,530 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-08-03$17.00/sh+875,000→ 2,273,530 total
Conversion
Omega Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-08-03−5,000,000→ 0 total
Purchase
Omega Therapeutics, Inc.
Common Stock
2021-07-30$16.14/sh+75,000→ 75,000 total
Sale
Seer, Inc.$SEER
Class A Common Stock
2021-02-01$64.15/sh−252,545→ 5,588,366 total
Purchase
LEXICON PHARMACEUTICALS, INC.$LXRX
Common Stock
2020-12-16$3.20/sh+10,937,500→ 32,259,461 total
Conversion
Seer, Inc.$SEER
Series C Convertible Preferred Stock
2020-12-08−373,831→ 0 total
Conversion
Seer, Inc.$SEER
Series D-1 Convertible Preferred Stock
2020-12-08−249,221→ 0 total
Conversion
Seer, Inc.$SEER
Series B Convertible Preferred Stock
2020-12-08−3,953,381→ 0 total

Companies

Recent Filings

Address

C/O CERES, INC. 1535 RANCHO CONEJO BOULEVARD

THOUSAND OAKS, CA, 91320

View on SEC.gov